oasis 1 trial oral semaglutide 50 mg weight loss results May be Effective Option for Obesity Treatment, According to Study Authors Efficacy and safety of once-daily

The proportion of patients with PCOS who were prescribed semaglutide or tirzepatide increased from 2.4% in 2021 to 17.6% in 2025, representing a 637.5% relative increase

PlexusDx helps clarify these concerns through personalized treatment approaches backed by genetic insight

They are the direct result of the medication doing exactly what it was designed to do: slowing down your digestion to help you feel full and satisfied

International Journal of Cardiology, 322 , 915

We offer ongoing support and follow-up to monitor progress, adjust treatments as needed, and provide guidance on complementary lifestyle changes that can support recovery